United States · Bill · HR
H.R. 6342 (116th)
SBIC Capital Infusion Act of 2020
Introduced
23 March 2020
Last action
—
Status
Referred to the House Committee on Small Business.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
SBIC Capital Infusion Act of 2020 This bill provides economic assistance to small businesses affected by COVID-19 (i.e., coronavirus disease 2019), and it reestablishes the New Markets Venture Capital Program. Specifically, the bill provides additional leverage for small business investment companies (SBICs) by requiring the Small Business Administration (SBA), when calculating the maximum amount of outstanding leverage made available to SBICs, to exclude a certain amount of outstanding leverage to small businesses affected by COVID-19. Any excluded amounts must be used solely for working capital purposes. The bill also reestablishes the New Markets Venture Capital Program, through which the SBA, in partnership with investment companies, encourages developmental venture capital investment in small businesses located in low-income areas.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 23 March 2020
Introduced in House (PDF)
Introduced in House · EN · 23 March 2020
Introduced in House
summary · EN · 23 March 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/6342
- Open data entity: https://api.congress.gov/v3/bill/116/hr/6342